MRKR Marker Therapeutics Inc

P/E --
Forward P/E --
Price/Sales 6.86
Beta 1.514
Div Yield --
Market Cap --

Company Analysis

Latest News

🟢 Marker Therapeutics is trading 11% up today as biotech rebound continues

Marker Therapeutics is trading 11% up today at $1.25 amid a broader biotech-led rebound and a general risk-on tone in U.S. equities. • The move appears tied...

🟢 Marker Therapeutics is trading 6.2% up today as biotech-led rebound continues

Marker Therapeutics is trading 6.2% up at $1.25 today, extending a biotech-led rebound that began late last week. • The move occurs despite a lack of fresh...

🟢 Marker Therapeutics is trading 6.7% up today amid a broader biotech rally

Marker Therapeutics is trading 6.7% up at $1.20 amid a broader rally in the biotechnology sector despite a lack of company-specific news. • The move appears...

🔴 Marker Therapeutics is trading 7.5% down today amid thin after-hours liquidity and broader market weakness

Marker Therapeutics is trading at $1.03 (-7.54%) in after-hours trading as a broader risk-off market backdrop and Fed-related sentiment weigh on the stock. •...

🔴 Marker Therapeutics is trading 5.7% down today on profit-taking and weak biotech sentiment

Marker Therapeutics is trading 5.7% down at $1.33 amid ongoing volatility and profit-taking following a sharp multi-month run-up driven by positive...

Marker Therapeutics Retains Buy Rating, Eyes Single-Arm Trial for Registration

Marker Therapeutics Retains Buy Rating, Eyes Single-Arm Trial for Registration

H.C. Wainwright reiterated a Buy rating for Marker Therapeutics with a $10.00 price target. Management expects a single-arm Phase 2 trial could support...

🔴 MRKR is trading 5.4% down today on profit-taking and broader market weakness

MRKR is trading at $1.59, down 5.4% today on profit-taking and broader market weakness following a sharp 13.5% gain on July 7. - No fresh company-specific...

🔴 MRKR is trading 7.1% down today as it pulls back from yesterday's gains

MRKR is trading at $1.56 (down 7.1%) as the stock pulls back from a sharp 13.5% gain on July 07, 2026, amid a broadly weaker market. • No fresh...

🟢 MRKR makes sharp 10.8% jump

MRKR is trading at $1.64, up 10.8% versus the comparison close of $1.48 during regular trading. This is a price-movement alert; no separate company-specific...

🟢 MRKR is trading 5.4% up today, extending its recent upward trend

MRKR is trading 5.4% up at $1.56 today, continuing a positive trajectory that began in late June despite a lack of new company-specific catalysts. - No fresh...

🟢 MRKR makes sharp 10.5% jump

MRKR is trading at $1.45, up 10.5% versus the comparison close of $1.31 during regular trading. This is a price-movement alert; no separate company-specific...

🟢 MRKR is trading 5.2% up today amid broad biotech risk-on sentiment

MRKR is trading 5.2% up at $1.38 as biotech names benefit from a stronger risk-on session and higher U.S. indexes. • No confirmed company-specific news,...

🟢 MRKR is trading 5.7% up today amid broad pre-market risk-on sentiment

MRKR is trading at $1.39 (+5.70%) in pre-market, likely driven by broad risk-on sentiment as U.S. index futures trend higher and biotech names benefit from a...